Patent · US Active

1,5-substituted indol-2-yl amide derivatives

US7745479B2 · kind B2 · utility

24Cited by

10References

22Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Matthias Nettekoven · Weil am Rhein, DE
Jean-Marc Plancher · Rixheim, FR
Hans Richter · Weil am Rhein, DE
Olivier Roche · Folgensbourg, FR
Valerie Runtz-Schmitt · Basel, CH
Sven Taylor · Riedisheim, FR

Key dates

Filing date	Nov 27, 2006
Grant date	Jun 29, 2010
Priority date	—
Expiry date	Jun 27, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula Iwherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.